Showing results (881-890 of 1,129) with videos related to
Sort By:
Pageof 113
Best Practice & Research. Clinical Haematology|November 30, 2019
Does mutational burden add to other prognostic factors in MDS?Aziz NazhaBest Practice & Research. Clinical Haematology|November 30, 2019
Transplantation without pretransplant therapy: Is this a possibility? Insights into providing transplantation at diagnosis for patients with acute leukemiaNelson J ChaoBest Practice & Research. Clinical Haematology|December 6, 2020
CD123 bi-specific antibodies in development in AML: What do we know so far?Michael J Slade, Geoffrey L UyBest Practice & Research. Clinical Haematology|December 6, 2020
CD33 directed bispecific antibodies in acute myeloid leukemiaMary C Clark, Anthony SteinBest Practice & Research. Clinical Haematology|December 6, 2020
Antibody based therapy in relapsed acute lymphoblastic leukemiaNadya Jammal, Serena Chew, Elias Jabbour, et al.Best Practice & Research. Clinical Haematology|December 6, 2020
Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?Jan Philipp Bewersdorf, Amer M ZeidanBest Practice & Research. Clinical Haematology|March 25, 2021
Is there evidence for the use of FLT3 inhibitors as maintenance therapy in AML?Mark LevisBest Practice & Research. Clinical Haematology|March 25, 2021
Molecular alterations governing predisposition to myelodysplastic syndromes: Insights from Shwachman-Diamond syndromeAkiko ShimamuraBest Practice & Research. Clinical Haematology|March 25, 2021
Progress in the management of chronic GVHD insights into novel therapies to treat and manage GVHD lasting longer than 12 MonthsMary E D FlowersBest Practice & Research. Clinical Haematology|March 25, 2021
Overcoming graft failure after haploidentical transplantation: Is this a possibility?Xiao-Jun HuangPageof 113